The 0.5% incidence rate detected using multigene panel testing strategy in our consecutive cancer patients is similar to those reported by Rana et al. They detected 126 TP53 mutant cases out of 40,885 tested cancer patients (0.3%)23. This evidence concerns the gene TP53 and cancer.